This is one step towards Altman's YC, which has only been pushing the envelope further and further on what an incubator is. Interested too see how this pans out :)
* taking more "hard science" companies in YC (fusion, biotech, etc)
* taking later stage companies (Quora, others?)
* getting aggressive about scaling YC #s
I'm sure I'm missing some as well